SCYNEXIS (SCYX)

[dutur]

I have some SCYX stock @2,77, i think that it's necex to wait for a new FDA indication.
Very frustrating to see so little info from IR about these surprising event.

No answer about:
1- trombotic events are site-dependent or only concentration-dependent?
2- the concentration trombogenic is therapeutical concentration?
3- hold is for changing utlization way or only a new control of real mechanism to make this armful event?
4- cost impact of this holding? simply a hpothesis..

see you later

I have many hopes about scynexis
JD